+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NK Cell Cytotoxicity Assay Service Market - Global Forecast 2026-2032- Product Image
NK Cell Cytotoxicity Assay Service Market - Global Forecast 2026-2032- Product Image
Sale

NK Cell Cytotoxicity Assay Service Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283504
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

NK Cell Cytotoxicity Assay Services: Executive Summary

NK cell cytotoxicity assay services support the evaluation of natural killer cell function, target-cell susceptibility, and immune-mediated killing across research, translational, and drug-development programs. Service offerings commonly combine donor or engineered NK-cell preparation, target-cell handling, assay execution, controls, data analysis, and reporting. Demand is shaped by the need for reproducible functional evidence in immuno-oncology, cell therapy, infectious-disease research, and broader immune-function studies.

Standardization and Translational Relevance Are Reshaping Assay Workflows

The service landscape is shifting from isolated endpoint testing toward more integrated and decision-ready workflows. Clients increasingly require clear controls, documented donor characteristics, validated target-cell models, transparent acceptance criteria, and fit-for-purpose data interpretation. Multiparametric readouts, time-resolved measurements, automation, and standardized reporting can improve comparability across studies, while assay customization remains important for distinct therapeutic mechanisms and biological questions. Regulatory expectations and the need to connect in-vitro findings with downstream studies are also encouraging stronger documentation and method qualification.

Artificial Intelligence Is Strengthening Design, Analysis, and Quality Control

Artificial intelligence can support NK cell cytotoxicity assay services by assisting image analysis, identifying cellular phenotypes, flagging anomalous wells, and improving interpretation of complex multiparametric datasets. Machine-learning tools may also help optimize experimental conditions, prioritize controls, and detect batch-related variation when trained on sufficiently curated data. Their practical value depends on representative training datasets, traceable model outputs, human review, and validation against established biological and analytical benchmarks. AI should therefore augment assay scientists rather than replace experimental controls or expert assessment.

Regional Insights: Capability, Regulation, and Access Vary by Geography

North America combines strong translational research capacity, extensive biotechnology activity, and demand for outsourced functional testing. Europe emphasizes method comparability, data integrity, and alignment with structured regulatory and quality expectations across the region. Asia-Pacific is supported by expanding biomedical research infrastructure and growing interest in advanced cellular assays, although capabilities and access differ among economies. Latin America is developing service capacity through academic and clinical research networks, with procurement, logistics, and specialized instrumentation affecting adoption. The Middle East is building biomedical capabilities through institutional investment and partnerships, while Africa presents emerging opportunities alongside constraints related to laboratory infrastructure, specialist expertise, and sample logistics.

Group Insights: Economic and Strategic Blocs Shape Research Collaboration

ASEAN markets are strengthening regional research links and may benefit from shared laboratory resources, though service maturity is uneven. BRICS countries span substantial scientific and healthcare diversity, creating opportunities for domestic capability development and cross-border collaboration while also requiring careful attention to harmonized protocols. The European Union benefits from coordinated research frameworks and common regulatory principles. G7 members generally contribute mature research ecosystems, advanced instrumentation, and strong quality systems. GCC countries are expanding biomedical infrastructure and international partnerships. NATO members include diverse national capabilities, but collaboration across the alliance can support common standards, resilience, and access to specialized research services.

Country Insights: National Strengths and Constraints Define Service Adoption

Australia supports biomedical research through established academic and clinical networks, while Brazil is expanding translational capacity amid regional infrastructure variation. Canada offers strong life-science research capabilities and collaborative institutions. China is advancing cell and molecular research infrastructure at scale, and India combines a broad scientific workforce with growing demand for specialized testing. Japan and South Korea maintain sophisticated biotechnology ecosystems with emphasis on quality and technical precision. France, Germany, Italy, Spain, and the United Kingdom contribute mature European research and regulatory environments, with differences in procurement and institutional organization. The United States has extensive immunology, oncology, and biotechnology activity. Mexico is developing its research and contract-service base. Russia retains relevant scientific expertise, although collaboration, access, and supply-chain conditions can affect service execution.

Actions for Leaders: Build Reproducible, Flexible, and Decision-Ready Services

Industry leaders should define assay fit-for-purpose criteria before study initiation and document donor selection, target-cell provenance, effector-to-target ratios, controls, readouts, and acceptance thresholds. Investing in qualified automation, reference materials, interoperable data systems, and analyst training can improve reproducibility. Service providers should offer modular protocols that accommodate primary cells, engineered effectors, diverse targets, and multiparametric endpoints without compromising comparability. Responsible AI adoption should include locked validation datasets, audit trails, bias checks, and expert review. Regional partnerships, resilient sample logistics, and transparent reporting can further improve access and support multinational programs.

Methodology: Evidence-Based Synthesis of Assay-Service Dynamics

This executive summary uses the defined market scope of NK cell cytotoxicity assay services and synthesizes established characteristics of functional natural-killer-cell testing, outsourced laboratory workflows, translational research needs, and regional biomedical environments. Insights are organized across technology, service delivery, geography, economic groupings, and national research ecosystems. The analysis intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Regional and country observations are qualitative and should be validated against current laboratory accreditation, regulatory, procurement, and infrastructure data before operational decisions are made.

Conclusion: Reliability and Biological Relevance Will Differentiate Providers

NK cell cytotoxicity assay services are becoming more important as researchers seek reproducible functional evidence for immune-cell biology and therapeutic development. Competitive differentiation will depend less on a single assay format and more on integrated quality systems, transparent interpretation, adaptable study design, and credible links between experimental outputs and translational decisions. Providers and users that combine validated biology, disciplined operations, responsible analytics, and regionally resilient delivery will be better positioned to support complex research programs.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. NK Cell Cytotoxicity Assay Service Market, by Assay Method
7.1. Introduction
7.2. Chromium-51 (5¹Cr) Release Assay
7.3. Lactate Dehydrogenase (LDH) Release Assay
7.4. Flow Cytometry-Based Cytotoxicity Assay
7.5. PI Staining Assay
7.6. PI Apoptosis Assay
7.7. Real-Time Cell Analysis
7.8. Bioluminescence-Based Cytotoxicity Assay
7.9. Calcein-AM Release Assay
7.10. Microfluidics-Based Cytotoxicity Assay
8. NK Cell Cytotoxicity Assay Service Market, by NK Cell Source
8.1. Introduction
8.2. Primary Human NK Cells
8.3. Autologous NK Cells
8.4. Allogeneic NK Cells
8.5. Peripheral Blood Mononuclear Cell (PBMC)-Derived NK Cells
8.6. Cord Blood-Derived NK Cells
8.7. CAR-NK Cells
9. NK Cell Cytotoxicity Assay Service Market, by Target Cell Type
9.1. Introduction
9.2. Tumor Cell Lines
9.3. Primary Tumor Cells
9.4. Solid Tumor Cells
9.5. Hematological Malignancy Cells
9.6. Bacteria-Infected Cells
9.7. Stem Cell-Derived Target Cells
9.8. Antigen-Expressing Engineered Cells
10. NK Cell Cytotoxicity Assay Service Market, by End-User
10.1. Introduction
10.2. Pharmaceutical Companies
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Academic & Research Institutes
10.6. Hospitals & Clinical Research Centers
10.7. Government & Defense Research Labs
10.8. Cell Therapy Developers
11. NK Cell Cytotoxicity Assay Service Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. NK Cell Cytotoxicity Assay Service Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. NK Cell Cytotoxicity Assay Service Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Charles River Laboratories International, Inc.
15.2. Crown Bioscience, Inc.
15.3. Eurofins Scientific SE
15.4. Evotec SE
15.5. GenScript Biotech Corporation
15.6. ICON plc
15.7. IQVIA Holdings Inc.
15.8. Jubilant Biosys Limited
15.9. Lonza Group AG
15.10. Medpace Holdings, Inc.
15.11. Oncodesign SA
15.12. Pharmaron Beijing Co., Ltd.
15.13. SGS S.A.
15.14. Syngene International Limited
15.15. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global NK Cell Cytotoxicity Assay Service Market, Years Considered for the Study
FIGURE 2. Global NK Cell Cytotoxicity Assay Service Market, Research Design
FIGURE 3. Global NK Cell Cytotoxicity Assay Service Market, Research Framework
FIGURE 4. Global NK Cell Cytotoxicity Assay Service Market, Data Triangulation
FIGURE 5. Global NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2025 vs 2032 (%)
FIGURE 7. Global NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2025 vs 2032 (%)
FIGURE 9. Global NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2025 vs 2032 (%)
FIGURE 11. Global NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global NK Cell Cytotoxicity Assay Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global NK Cell Cytotoxicity Assay Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global NK Cell Cytotoxicity Assay Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global NK Cell Cytotoxicity Assay Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global NK Cell Cytotoxicity Assay Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global NK Cell Cytotoxicity Assay Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global NK Cell Cytotoxicity Assay Service Market Segmentation & Coverage
TABLE 2. Global NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 4. Global Chromium-51 (5¹Cr) Release Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chromium-51 (5¹Cr) Release Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chromium-51 (5¹Cr) Release Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Lactate Dehydrogenase (LDH) Release Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Lactate Dehydrogenase (LDH) Release Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Lactate Dehydrogenase (LDH) Release Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Flow Cytometry-Based Cytotoxicity Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Flow Cytometry-Based Cytotoxicity Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Flow Cytometry-Based Cytotoxicity Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global PI Staining Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global PI Staining Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global PI Staining Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global PI Apoptosis Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global PI Apoptosis Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global PI Apoptosis Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Real-Time Cell Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Real-Time Cell Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Real-Time Cell Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Bioluminescence-Based Cytotoxicity Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Bioluminescence-Based Cytotoxicity Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Bioluminescence-Based Cytotoxicity Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Calcein-AM Release Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Calcein-AM Release Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Calcein-AM Release Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Microfluidics-Based Cytotoxicity Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Microfluidics-Based Cytotoxicity Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Microfluidics-Based Cytotoxicity Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 32. Global Primary Human NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Primary Human NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Primary Human NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Autologous NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Autologous NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Autologous NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Allogeneic NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Allogeneic NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Allogeneic NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Peripheral Blood Mononuclear Cell (PBMC)-Derived NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Peripheral Blood Mononuclear Cell (PBMC)-Derived NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Peripheral Blood Mononuclear Cell (PBMC)-Derived NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Cord Blood-Derived NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Cord Blood-Derived NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Cord Blood-Derived NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global CAR-NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global CAR-NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global CAR-NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 51. Global Tumor Cell Lines Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Tumor Cell Lines Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Tumor Cell Lines Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Primary Tumor Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Primary Tumor Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Primary Tumor Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Solid Tumor Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Solid Tumor Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Solid Tumor Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Hematological Malignancy Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Hematological Malignancy Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Hematological Malignancy Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Bacteria-Infected Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Bacteria-Infected Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Bacteria-Infected Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Stem Cell-Derived Target Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Stem Cell-Derived Target Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Stem Cell-Derived Target Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Antigen-Expressing Engineered Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Antigen-Expressing Engineered Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Antigen-Expressing Engineered Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 73. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Hospitals & Clinical Research Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Hospitals & Clinical Research Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Hospitals & Clinical Research Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Government & Defense Research Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Government & Defense Research Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Government & Defense Research Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Cell Therapy Developers Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Cell Therapy Developers Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Cell Therapy Developers Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 100. North America NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. North America NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 102. North America NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 103. North America NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 104. North America NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 105. Latin America NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 107. Latin America NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 108. Latin America NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 109. Latin America NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 110. Europe NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Europe NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 112. Europe NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 113. Europe NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 114. Europe NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 115. Middle East NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 117. Middle East NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 118. Middle East NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 119. Middle East NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 120. Africa NK Cell Cytotoxicity Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Africa NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 122. Africa NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 123. Africa NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 124. Africa NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 125. Global NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 128. ASEAN NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 129. ASEAN NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 130. ASEAN NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 131. GCC NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. GCC NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 133. GCC NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 134. GCC NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 135. GCC NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 136. European Union NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. European Union NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 138. European Union NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 139. European Union NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 140. European Union NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 141. BRICS NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. BRICS NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 143. BRICS NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 144. BRICS NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 145. BRICS NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 146. G7 NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. G7 NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 148. G7 NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 149. G7 NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 150. G7 NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 151. NATO NK Cell Cytotoxicity Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. NATO NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 153. NATO NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 154. NATO NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 155. NATO NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 156. Global NK Cell Cytotoxicity Assay Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. United States NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 158. United States NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 159. United States NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 160. United States NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 161. United States NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. Canada NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 163. Canada NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 164. Canada NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 165. Canada NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 166. Canada NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 167. Mexico NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 168. Mexico NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 169. Mexico NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 170. Mexico NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 171. Mexico NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 172. Brazil NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 173. Brazil NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 174. Brazil NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 175. Brazil NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 176. Brazil NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 177. United Kingdom NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 178. United Kingdom NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 179. United Kingdom NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 180. United Kingdom NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 181. United Kingdom NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 182. Germany NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 183. Germany NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 184. Germany NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 185. Germany NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 186. Germany NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. France NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 188. France NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 189. France NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 190. France NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 191. France NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 192. Russia NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 193. Russia NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 194. Russia NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 195. Russia NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 196. Russia NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 197. Italy NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 198. Italy NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 199. Italy NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 200. Italy NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 201. Italy NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 202. Spain NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 203. Spain NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 204. Spain NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 205. Spain NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 206. Spain NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 207. China NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 208. China NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 209. China NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 210. China NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 211. China NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 212. India NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 213. India NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 214. India NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 215. India NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 216. India NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 217. Japan NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 218. Japan NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 219. Japan NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 220. Japan NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 221. Japan NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 222. Australia NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 223. Australia NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 224. Australia NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 225. Australia NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 226. Australia NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 227. South Korea NK Cell Cytotoxicity Assay Service Market Size, 2017-2032 (USD Million)
TABLE 228. South Korea NK Cell Cytotoxicity Assay Service Market Size, by Assay Method, 2017-2032 (USD Million)
TABLE 229. South Korea NK Cell Cytotoxicity Assay Service Market Size, by NK Cell Source, 2017-2032 (USD Million)
TABLE 230. South Korea NK Cell Cytotoxicity Assay Service Market Size, by Target Cell Type, 2017-2032 (USD Million)
TABLE 231. South Korea NK Cell Cytotoxicity Assay Service Market Size, by End-User, 2017-2032 (USD Million)
TABLE 232. Global NK Cell Cytotoxicity Assay Service Market Share, by Key Player, 2025
TABLE 233. Global NK Cell Cytotoxicity Assay Service Market, Key Experts

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • GenScript Biotech Corporation
  • ICON plc
  • IQVIA Holdings Inc.
  • Jubilant Biosys Limited
  • Lonza Group AG
  • Medpace Holdings, Inc.
  • Oncodesign SA
  • Pharmaron Beijing Co., Ltd.
  • SGS S.A.
  • Syngene International Limited
  • WuXi AppTec Co., Ltd.

Related Reports

Immune Mediated Tumor Killing Assays Service Market - Global Forecast 2026-2032 - Product Image

Immune Mediated Tumor Killing Assays Service Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Advanced Methodologies to Study and Enhance Cellular Cytotoxicity Against Cancer. Methods in Cell Biology Volume 207 - Product Image

Advanced Methodologies to Study and Enhance Cellular Cytotoxicity Against Cancer. Methods in Cell Biology Volume 207

  • Book
The Immunological Synapse Part C. Methods in Cell Biology Volume 193 - Product Image

The Immunological Synapse Part C. Methods in Cell Biology Volume 193

  • Book
Immuno-oncology and immunotherapy Part A. Methods in Cell Biology Volume 189 - Product Image

Immuno-oncology and immunotherapy Part A. Methods in Cell Biology Volume 189

  • Book
NK Cell Expansion Kit Market - Global Forecast 2026-2032 - Product Image

NK Cell Expansion Kit Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.